دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Impact of Left Ventricular Papillary Muscle Ventricular Arrhythmia Ablation on Mitral Valve Function
Jennifer Chee, MD, Aung N. Lin, MD, Howard Julien, MD, David Lin, MD, Robert D. Schaller, DO, David S. Frankel, MD, Gregory E. Supple, MD, Pasquale Santangeli, MD, PHD, Michael P. Riley, MD, PH D, Saman Nazarian, MD, P HD, Rajat Deo, MD, Jeffrey Arkles, MD, Ramanan Kumareswaran, MD, Matthew C. Hyman, MD, PHD, Gustavo Guandalini, MD, Andrew E. Epstein, MD, Erica S. Zado, PA-C, David J. Callans, MD, Francis E. Marchlinski, MD, Sanjay Dixit, MD
doi : 10.1016/j.jacep.2022.07.025
Volume 8, Issue 12, December 2022, Pages 1475-1483
Although efficacious, catheter ablation (CA) of ventricular arrhythmias (VAs) originating from left ventricular (LV) papillary muscles (PAPs) has the potential to affect mitral valve (MV) function.
Left Ventricular Papillary Muscle Ablation: A Mountain of Challenges
Eric N. Prystowsky, MD, a,b Parin Patel, MD
doi : 10.1016/j.jacep.2022.08.030
Volume 8, Issue 12, December 2022, Pages 1484-1485
Effect of Epicardial Pulsed Field Ablation Directly on Coronary Arteries
Satoshi Higuchi, MD,a Sung Il Im, MD, a Carol Stillson, BS, a Eric D. Buck, MS, b Samantha Jerrell, BS,b Christopher W. Schneider, ME NG,b Molly Speltz, DVM,c Edward P. Gerstenfeld, MD
doi : 10.1016/j.jacep.2022.09.003
Volume 8, Issue 12, December 2022, Pages 1486-1496
The unique tissue selectivity of pulsed field ablation (PFA) allows for minimizing collateral damage to the nerves/esophagus. However, the safety profile of epicardial PFA on coronary arteries (CAs) has not been well defined.
Pulsed-Field Ablation and the Coronary Arteries: Not So Simple
David J. Wilber, MD
doi : 10.1016/j.jacep.2022.11.006
Volume 8, Issue 12, December 2022, Pages 1497-1499
QT Prolongation and In-Hospital Ventricular Arrhythmic Complications in Patients With Apical Ballooning Takotsubo Syndrome
Marco Giuseppe Del Buono, MD, a,b Juan Ignacio Damonte, MD, a,c Francesco Moroni, MD, g Krishna Ravindra, BS, a Peter Westman, MD, a Juan G. Chiabrando, MD,a,c Edoardo Bressi, MD,a Pengyang Li, MD, a Kunal Kapoor, MD,a Yuxuan Mao, MD, a Travis Oakes, DS,d Paula Rodriguez-Miguelez, PHD, e Tamas S. Gal, PH D, f Jayanthi Koneru, MD,a Kenneth A. Ellenbogen, MD,a Jordana Kron, MD, a Antonio Abbate, MD, P HD
doi : 10.1016/j.jacep.2022.08.010
Volume 8, Issue 12, December 2022, Pages 1500-1510
Takotsubo syndrome is associated with life threatening arrhythmias, and the apical ballooning pattern is characterized by a peculiar QT prolongation and particularly high-risk of arrhythmias.
Ventricular Arrhythmic Risk in Takotsubo Syndrome: Clinical Subtype Matters∗
Katherine C. Wu, MD, Ilan S. Wittstein, MD
doi : 10.1016/j.jacep.2022.10.009
Volume 8, Issue 12, December 2022, Pages 1511-1514
Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation
Timothy M. Markman, MD, Andrew A. Jarrah, MD, Ye Tian, MD, Evan Mustin, Gustavo S. Guandalini, MD, David Lin, MD, Andrew E. Epstein, MD, Matthew C. Hyman, MD, PH D, Rajat Deo, MD, Gregory E. Supple, MD, Jeffrey S. Arkles, MD, Sanjay Dixit, MD, Robert D. Schaller, DO, Pasquale Santangeli, MD, Saman Nazarian, MD, P HD, Michael Riley, MD, PHD, David J. Callans, MD, Francis E. Marchlinski, MD, David S. Frankel, MD
doi : 10.1016/j.jacep.2022.07.010
Volume 8, Issue 12, December 2022, Pages 1515-1520
Guidelines recommend that initial trial of a “pill-in-the-pocket� (PIP) Class 1C antiarrhythmic drug (AAD) for cardioversion of atrial fibrillation (AF) be performed in a monitored setting because of the potential for adverse reactions.
Pill in the Pocket: A Safe and Useful Antiarrhythmic Strategy∗
Alessandro Capucci, MD
doi : 10.1016/j.jacep.2022.11.001
Volume 8, Issue 12, December 2022, Pages 1521-1522
Serial 7-Day Electrocardiogram Patch Screening for AF in High-Risk Older Women by the CHARGE-AF Score
Jeffrey Y. Lin, MD,a Joseph Larson, MS, b Jenny Schoenberg, BS, b Alejandra Sepulveda, BS, a Lesley Tinker, PHD, RD, b Matthew Wheeler, MD, a Christine Albert, MD, MPH,c JoAnn E. Manson, MD, D R PH, d Gretchen Wells, MD, P HD, e Lisa W. Martin, MD,f Victor Froelicher, MD, a Mike LaMonte, PHD, MPH,g Charles Kooperberg, PH D, b Mark A. Hlatky, MD,a Philip Greenland, MD, h Marcia L. Stefanick, PHD, a Marco V. Perez, MD
doi : 10.1016/j.jacep.2022.08.024
Volume 8, Issue 12, December 2022, Pages 1523-1534
Asymptomatic atrial fibrillation (AF) is associated with an increased risk of stroke. The yield of serial electrocardiographic (ECG) screening for AF is unknown.
Primum Non Nocere: Serial Screening for AF, Who, How, and Why?∗
Prashanthan Sanders, MBBS, P HD, a,b Suraya H. Kamsani, MBBS, a,b Melissa E. Middeldorp, MPH, PH D
doi : 10.1016/j.jacep.2022.09.014
Volume 8, Issue 12, December 2022, Pages 1535-1538
Omnipolar Versus Bipolar Electrode Mapping in Patients With Atrial Fibrillation Undergoing Catheter Ablation
Maham F. Karatela, BA,a,b Robert S. Dowell, BSN, a,c Daniel Friedman, MD,a,b Kevin P. Jackson, MD, a,b Jonathan P. Piccini, MD, MHS
doi : 10.1016/j.jacep.2022.08.026
Volume 8, Issue 12, December 2022, Pages 1539-1552
Peak-to-peak bipolar voltage varies with electrode orientation, fractionation, and collision events. Novel, omnipolar mapping is less dependent on electrode orientation but has limited data in humans.
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Therapy in Women: A Propensity Score-Matched Analysis
Giampiero Maglia, MD, a Massimo Giammaria, MD,b Gabriele Zanotto, MD, c Antonio D’Onofrio, MD, d Paolo Della Bella, MD, e Massimiliano Marini, MD,f Giovanni Rovaris, MD, g Saverio Iacopino, MD,h Valeria Calvi, MD, i Ennio C. Pisanò, MD,j Matteo Ziacchi, MD, P HD, k Antonio Curnis, MD, l Gaetano Senatore, MD, m Fabrizio Caravati, MD, n Davide Saporito, MD, o Giovanni B. Forleo, MD, PHD, p Stefano Pedretti, MD,q Vincenzo Ezio Santobuono, MD, P HD, r Patrizia Pepi, MD,s Alberto De Salvia, MD,t Giulia Balestri, MD,u Massimiliano Maines, MD, v Daniela Orsida, MD, w Giovanni Bisignani, MD, x Matteo Baroni, MD, y Fabio Lissoni, MD,z Matteo Bertini, MD, P HD, aa Daniele Giacopelli, MSC ,bb,cc Alessio Gargaro, MS C,bb Mauro Biffi, MD
doi : 10.1016/j.jacep.2022.08.002
Volume 8, Issue 12, December 2022, Pages 1553-1562
Causes of sex differences in incidence of sustained ventricular arrhythmias (SVAs) are poorly understood.
Sex Differences in Sustained Ventricular Arrhythmias: A Continuing Dialogue∗
Kamala P. Tamirisa, MD,a Sana M. Al-Khatib, MD, MHS
doi : 10.1016/j.jacep.2022.11.009
Volume 8, Issue 12, December 2022, Pages 1563-1565
Causes of Early Mortality After Transvenous Lead Removal
Justin Z. Lee, MD, a Min-Choon Tan, MD, a Suganya Karikalan, MBBS, a Abhishek J. Deshmukh, MD,b Dan Sorajja, MD, a Arturo Valverde, MD, a Komandoor Srivathsan, MD,a Luis Scott, MD,a Fred M. Kusumoto, MD,c Paul A. Friedman, MD,b Samuel J. Asirvatham, MD,b Siva K. Mulpuru, MD,b Yong-Mei Cha, MD
doi : 10.1016/j.jacep.2022.08.006
Volume 8, Issue 12, December 2022, Pages 1566-1575
Recognition of the causes of early mortality (≤30 days) after transvenous lead removal (TLR) is an essential step for the development of quality improvement programs.
Transvenous Lead Extraction: Toward a Better Understanding of Mortality Outcomes∗
Bruce A. Koplan, MD, MPH, Sunil Kapur, MD
doi : 10.1016/j.jacep.2022.11.008
Volume 8, Issue 12, December 2022, Pages 1576-1578
Coronary Arterial Spasm and Pulsed Field Ablation: Preclinical Insights
Jacob S. Koruth, MD Iwanari Kawamura, MD Eric Buck, MS Samantha Jerrell, BS Richard Brose, MS Vivek Y. Reddy, MD
doi : 10.1016/j.jacep.2022.06.015
Volume 8, Issue 12, December 2022, Pages 1579-1580
Echocardiogram-Guided Leadless Pacemaker Implantation
Rahul Bhardwaj, MD Jakrin Kewcharoen, MD Tahmeed Contractor, MD Srishti Nayak, MD Saif Ai, MD Uoo Kim, MD Ravi Mandapati, MD Jalaj Garg, MD
doi : 10.1016/j.jacep.2022.06.023
Volume 8, Issue 12, December 2022, Pages 1581-1582
Impact of Bradyarrhythmias Requiring Pacing on Outcomes in Patients With COVID-19
Elena C. Vasti, MD, MPH Melanie D. Ashland, MS Christian O’Donnell, MD Fatima Rodriguez, MD, MPH Paul Wang, MDy *Connor G. O’Brien, MD
doi : 10.1016/j.jacep.2022.06.014
Volume 8, Issue 12, December 2022, Pages 1583-1585
Pill-in-the-Pocket Therapy for Atrial Fibrillation: Is There More to Say?
*James A. Reiffel, MD
doi : 10.1016/j.jacep.2022.09.025
Volume 8, Issue 12, December 2022, Pages 1585-1586
Reply: Pill-in-the-Pocket Therapy for Atrial Fibrillation: Is There More to Say?
Timothy M. Markman, MD Andrew E. Epstein, MD *David S. Frankel, MD
doi : 10.1016/j.jacep.2022.10.014
Volume 8, Issue 12, December 2022, Page 1586
Advances of Implantation Techniques for Conduction System Pacing
Wei Hua, MD, a, * Min Gu, MD, a, * Hongxia Niu, MD, a Michael R. Gold, MD, P HD
doi : 10.1016/j.jacep.2022.09.022
Volume 8, Issue 12, December 2022, Pages 1587-1598
A Global Look to the Future of Pediatric Electrophysiology∗
Mitchell I. Cohen, MD,a Anne M. Dubin,b Gregory Webster, MD, MPH,c Yaniv Bar-Cohen, MD, d Kara S. Motonaga, MD, b Thomas Kriebel, MD, e Shubhayan Sanatani, MD, f Eric Rosenthal, MD, g Jose Moltedo, MD, h Jun Yoshimoto, MD, i Andrew Davis, MB BS, MD, j George F. Van Hare, MD, k Susan P. Etheridge, MD
doi : 10.1016/j.jacep.2022.09.015
Volume 8, Issue 12, December 2022, Pages 1599-1602
Cardiac Magnetic Resonance and Segment of Origin Identification Algorithm Streamline Post-Myocardial Infarction Ventricular Tachycardia Ablation
Giulio Falasconi, MD, Diego Penela, MD, PH D, David Soto-Iglesias, MS C, PH D, Julio MartÃ-Almor, MD, P HD, Antonio Berruezo, MD, PH D
doi : 10.1016/j.jacep.2022.09.004
Volume 8, Issue 12, December 2022, Pages 1603-1608
3-Dimensional Intracardiac Echocardiography-Guided Percutaneous Closure of a Residual Leak via Radiofrequency Applications After LAAO
Domenico G. Della Rocca, MD, PH D, a,b Carola Gianni, MD, PH D, a Michele Magnocavallo, MD, a,c Sanghamitra Mohanty, MD, a Amin Al-Ahmad, MD, a David R. Tschopp, MD,a J. David Burkhardt, MD, a Luigi Di Biase, MD, PHD, a,d Rodney P. Horton, MD,a Andrea Natale, MD
doi : 10.1016/j.jacep.2022.09.019
Volume 8, Issue 12, December 2022, Pages 1609-1612
